Spineway - Asset Resilience Ratio
Spineway (ALSPW) has an Asset Resilience Ratio of -0.24% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Spineway (ALSPW) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2023)
This chart shows how Spineway's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Spineway total assets.
Liquid Assets Composition Over Time
This chart breaks down Spineway's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Spineway (ALSPW) investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-70.00K | -0.24% |
| Total Liquid Assets | €-70.00K | -0.24% |
Asset Resilience Insights
- Limited Liquidity: Spineway maintains only -0.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Spineway Industry Peers by Asset Resilience Ratio
Compare Spineway's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050 |
Medical Instruments & Supplies | 1.51% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Pro-Dex Inc
NASDAQ:PDEX |
Medical Instruments & Supplies | 1.39% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for Spineway (2011–2023)
The table below shows the annual Asset Resilience Ratio data for Spineway.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.26% | €-68.00K ≈ $-79.50K |
€26.31 Million ≈ $30.76 Million |
-19.81pp |
| 2021-12-31 | 19.56% | €5.00 Million ≈ $5.85 Million |
€25.57 Million ≈ $29.89 Million |
+21.17pp |
| 2020-12-31 | -1.61% | €-237.93K ≈ $-278.17K |
€14.75 Million ≈ $17.24 Million |
-16.63pp |
| 2016-12-31 | 15.02% | €1.42 Million ≈ $1.66 Million |
€9.45 Million ≈ $11.05 Million |
-0.47pp |
| 2015-12-31 | 15.48% | €1.39 Million ≈ $1.62 Million |
€8.96 Million ≈ $10.48 Million |
-7.33pp |
| 2014-12-31 | 22.81% | €2.56 Million ≈ $3.00 Million |
€11.24 Million ≈ $13.14 Million |
+21.82pp |
| 2012-12-31 | 1.00% | €49.00K ≈ $57.29K |
€4.91 Million ≈ $5.74 Million |
-0.17pp |
| 2011-12-31 | 1.17% | €43.80K ≈ $51.21K |
€3.74 Million ≈ $4.38 Million |
-- |
About Spineway
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more